Thursday, Dec 11 / 2025
Virtual Meeting
Download for Outlook/Apple Calendar Add to Google Calendar

Virtual Investor Alliance Forum

Keiretsu SoCal and TEN Capital Alliance
The Investor Alliance Forum unites top investor networks and founders for presentations, speed-matching, and high-impact collaboration.

The Investor Alliance Forum brings together leading angel networks, family offices, and venture partners from across the region to connect with high-growth entrepreneurs.

This exclusive event, sponsored by BakerHostetler, unites multiple investor alliances for a dynamic afternoon of founder presentations, speed-matching sessions, and curated networking — all designed to accelerate collaboration and deal flow across our shared ecosystem.

If you invest, advise, or champion innovation, this is where meaningful partnerships begin.

BakerHostetler is recognized as one of the top firms for client service and quality of legal services, BakerHostetler is a leading law firm that helps clients around the world address their most complex and critical business and regulatory issues.

Where Investors & Innovators Connect at the Speed of Opportunity

Event Agenda

12:00 PM – 1:00 PM
Check-In & Networking Lunch (In-Person Forum)
Arrive, connect, and enjoy lunch with fellow investors, founders, and partners.

1:00 PM The Virtual Forum Begins
Welcome & Partner Introductions
Opening remarks from Keiretsu Forum SoCal, Ten Capital, and our Event Partners.

1:30 PM
Company Presentations
Eight curated entrepreneurs present 5-minute pitches showcasing high-growth opportunities.

Closing Remarks
Wrap up the Virtual Forum with closing insights

SpeedMatch and Networking will continue with (In-Person) Forum

Presenting companies:

Leaf4Life
Leaf4Life

KizaVie™ (LEAF-4L6715) is a late-stage, first-in-class therapeutic platform designed to restore oxygen diffusion at the microvascular level—addressing a fundamental physiological limitation that drives mortality, treatment resistance, and healthcare burden across critical care, oncology, trauma, and chronic disease. Unlike conventional therapies that increase oxygen supply, KizaVie™ enables oxygen delivery at the tissue level, directly targeting a core biological failure not addressed by current standards of care.